[ELEVATION OF THE DEPRESSED THROMBOLYTIC ACTIVITY, IN ARTERIOSCLEROTICS SUBJECTED TO PROLONGED ORAL ANTICOAGULANT THERAPY, USING A DERIVATIVE OF NICOTINIC ACID].
D000614:Aminocaproates; D015119:Aminocaproic Acid; D000925:Anticoagulants; D001161:Arteriosclerosis; D001780:Blood Coagulation Tests; D002794:Choline; D005341:Fibrinolysin; D005342:Fibrinolysis; D008715:Methionine; D009525:Niacin; D010653:Phenylbutazone; D013927:Thrombosis
D000614:Aminocaproates; D000925:Anticoagulants; D009525:Niacin; D008715:Methionine; D005341:Fibrinolysin; D010653:Phenylbutazone; D002794:Choline; D015119:Aminocaproic Acid
AMINOCAPROIC ACID; ANTICOAGULANTS; ARTERIOSCLEROSIS; BLOOD COAGULATION TESTS; CHOLINE; FIBRINOLYSIN; METHIONINE; NICOTINIC ACID; PHENYLBUTAZONE; THROMBOSIS
ELEVACION DE LA ACTIVIDAD, TROMBOLITICA DEPRIMIDA, EN ATEROSCLEROSOS SOMETIDOS A TRATAMIENTO PROLONGADO CON ANTICOAGULANTES ORALES, UTILIZANDO UN DERIVADO DEL ACIDO NICOTINICO.